Companies /Healthcare

Henry Schein Inc

NASDAQ: HSIC Medical Distribution
$84.80
▼ $0.89 (−1.04%) today
Markets closed · 5:42pm ET

24/7 Wall St. View

HSIC at a Glance

Valuation
Market cap
$9.5B
P/E ratio
23.5
Profitability
Revenue (TTM)
$13.7B
Profit margin
3.1%
EPS (TTM)
$3.65
Price
52-week range
$69 – $92
24/7 target
$112.31
Street target
$96.87

Headquartered in Melville, NY Fiscal year ends December NASDAQ: HSIC henryschein.com

About Henry Schein

Henry Schein, Inc. (Nasdaq: HSIC) provides products, services and technology platforms to healthcare customers, primarily office-based dental and medical practitioners. It also serves dental laboratories, government and institutional healthcare clinics, and other alternate care sites.

The company reports results across several businesses:
- **Global Distribution and Value-Added Services**: dental merchandise, dental equipment, value-added services and medical distribution, split into U.S. and international operations.
- **Global Specialty Products**: a higher-margin business.
- **Global Technology**: practice management and related technology offerings.

With about 25,000 employees ('Team Schein Members'), it serves more than 1 million customers worldwide with more than 300 business, clinical, technology and supply chain solutions. It runs a centralized, automated distribution network offering more than 300,000 branded and Henry Schein corporate brand products, and has operations or affiliates in 34 countries and territories.

Sales reached $13.2 billion in 2025. The company is a FORTUNE 500 company and an S&P 500 member.

The company is pursuing value creation and restructuring initiatives and has a Strategic Partnership Agreement with KKR Hawaii Aggregator L.P., entered into in January 2025. It is also benefiting from IEEPA tariff refunds. Updated

Latest Activity

HSICHenry Schein
Q3 2026
EPS
$1.56
est $1.36+14.9%
Revenue
$3.47B
est $3.48B-0.1%

Henry Schein raised full-year adjusted EPS guidance to $5.50 to $5.56 from $5.29 to $5.39, signaling the dental recovery is taking hold. A tariff refund benefit flattered the quarter's earnings beat.

Quarterly EPS — reported vs estimate

HSIC Coverage

Frequently Asked Questions

What does Henry Schein do?

Henry Schein, Inc. (Nasdaq: HSIC) provides products, services and technology platforms to healthcare customers, primarily office-based dental and medical practitioners. It also serves dental laboratories, government and institutional healthcare clinics, and other alternate care sites.

What is the HSIC stock price target?

24/7 Wall St.'s 12-month price target for HSIC is $112.31, rated Buy. The Wall Street consensus target is $96.87. HSIC price prediction →